News
CYRX
16.00
+0.76%
0.12
Cryoport’s IntegriCell Cryopreservation Services Selected By Verismo Therapeutics To Support SynKIR-110 And SynKIR-310 Multi-Chain KIR-CAR Programs
Benzinga · 1d ago
Cryoport IntegriCell cryopreservation services win selection by Verismo Therapeutics for clinical KIR-CAR T trials
PUBT · 1d ago
Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs
PR Newswire · 1d ago
Analysts Offer Insights on Industrial Goods Companies: CryoPort (CYRX) and United Rentals (URI)
TipRanks · 1d ago
Cryoport deregisters expired common stock purchase warrants with SEC
PUBT · 4d ago
Weekly Report: what happened at CYRX last week (0615-0619)?
Weekly Report · 4d ago
Cryoport management to meet with Craig-Hallum
TipRanks · 06/16 20:16
Weekly Report: what happened at CYRX last week (0608-0612)?
Weekly Report · 06/15 09:39
Top CryoPort Executive Makes Major Stock Move That Investors Can’t Ignore
TipRanks · 06/13 02:15
Analysts Offer Insights on Industrial Goods Companies: CryoPort (CYRX) and Dolby Laboratories (DLB)
TipRanks · 06/11 14:00
Cryoport Shareholders Back Board, Auditor and Equity Plan
TipRanks · 06/09 22:33
Cryoport holds annual shareholder meeting; Deloitte appointment ratified
PUBT · 06/09 21:01
Cryoport CFO Robert Stefanovich disposes of 169,427 common shares worth $2.76 million
PUBT · 06/09 01:11
Cryoport director Ramkumar Mandalam disposes of 23,214 common shares for $358,366.62
PUBT · 06/09 01:05
Cryoport price target raised to $13.50 from $11 at Jefferies
TipRanks · 06/08 19:40
Weekly Report: what happened at CYRX last week (0601-0605)?
Weekly Report · 06/08 09:37
Cryoport raises FY2026 revenue outlook to $192-$196 million
PUBT · 06/03 22:47
Cryoport Is Maintained at Buy by Craig-Hallum
Dow Jones · 06/03 17:46
Craig-Hallum Maintains Buy on CryoPort, Raises Price Target to $20
Benzinga · 06/03 17:35
Cryoport price target raised to $20 from $15 at Craig-Hallum
TipRanks · 06/03 15:16
More
Webull provides a variety of real-time CYRX stock news. You can receive the latest news about Cryoport Inc through multiple platforms. This information may help you make smarter investment decisions.
About CYRX
Cryoport, Inc. is a provider of integrated, temperature-controlled supply chain solutions for the life sciences. The Company operates through two segments: segments: Life Sciences Services and Life Sciences Products. Its life sciences services include BioLogistics and BioStorage/BioServices, which provides temperature-controlled logistics, biostorage and bioservices within the life science industry through direct sales. Its life sciences products segment manufactures and sells cryogenic systems, such as freezers and cryogenic dewars and related ancillary accessories used in the storage and transport of life science commodities through direct sales or a distribution network. Its operating units include Cryoport Systems, CryoGene and MVE Biological Solutions (MVE). Cryoport Systems provides temperature-controlled BioLogistics, BioServices, and cryopreservation solutions, supporting clinical and commercial workflows through transport, kit production, labeling, packaging, and others.